enVVeno Medical Corporation Common Stock earnings per share and revenue
On Nov 03, 2025, NVNO reported earnings of -8.05 USD per share (EPS) for Q3 25, beating the estimate of -10.71 USD, resulting in a 24.84% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an decrease of -96.52% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.09%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were enVVeno Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, enVVeno Medical Corporation Common Stock reported EPS of -$8.05, beating estimates by 24.84%, and revenue of $0.00, 0% as expectations.
How did the market react to enVVeno Medical Corporation Common Stock's Q3 2025 earnings?
The stock price moved up 0.68%, changed from $0.70 before the earnings release to $0.71 the day after.
When is enVVeno Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for Feb 26, 2026.
What are the forecasts for enVVeno Medical Corporation Common Stock's next earnings report?
Based on 3
analysts, enVVeno Medical Corporation Common Stock is expected to report EPS of -$0.28 and revenue of -- for Q4 2025.